Across animals, nuclear receptors coordinate gene expression programs participating in major physiological, developmental and metabolic processes. Consistent with this notion, mutations in nuclear receptors are associated with human pathologies, including cancers, diabetes and heart disease. One important step towards our understanding of nuclear receptor function has come with the finding of a class of nuclear receptor co-regulators acting either as co-activators of activated nuclear receptors, or co-repressors of non-activated nuclear receptors [1] . In this issue of Current Biology, Francis et al.
[2] report the identification of dDOR, a new co-activator for the ecdysone receptor in the fruit fly Drosophila melanogaster. They demonstrate that dDOR is required in vivo for proper ecdysone signaling and that it provides a molecular connection with insulin signaling, therefore bridging two major signaling pathways involved in developmental timing, growth and metabolic homeostasis.
Over the past decades, Drosophila has emerged as an excellent working model for the study of nuclear receptors [3] . The Drosophila genome encodes only 18 nuclear receptors belonging to the 6 classes of nuclear receptors found in vertebrates. The receptor for ecdysone, the main steroid hormone of insects, has been studied particularly well. Ecdysone, or its active form 20-hydroxy-ecdysone (20E), controls the transition from the juvenile to the sexually mature state. In holometabolous insects -insects that undergo metamorphosis during a pupal stage -this transition takes place during metamorphosis and presents some parallels with the induction of sexual maturation by thyroid hormones and sex steroids in vertebrates. These parallels are reinforced at the molecular level by the nature of the respective receptors [9] . Nuclear DOR protein binds to TR1a, enhancing its transcriptional activity. In the absence of DOR, myogenesis is impaired, suggesting that its down-regulation in the Zucker rat could contribute to diabetes-associated TR1a dysfunction and muscular atrophy. Unraveling the in vivo function of this potentially interesting gene benefited from the use of the Drosophila model, for which a DOR ortholog could be found. dDOR, as it is named, comes in three isoforms, one long, one short and one long extended by a FENLL motif similar to the trans-activation domain of the human DOR (LEDLL). These isoforms are expressed in various tissues, including the larval fat body (the insect fat/liver) where the FENLL isoform shows prevalent expression during early metamorphosis. Knock-out of the dDOR gene led to developmental defects indicative of impaired ecdysone signaling. Mutant animals showed reduced viability and morphological defects due to abnormal metamorphosis. Accordingly, dDOR mutants show a diminished transcriptional response to ecdysone, particularly for the primary response genes (E75A, E74, BR-C) that normally get transcribed at the end of larval development. This is also true in fat tissue explants and in cultured cells where direct molecular interactions are observed between dDOR and EcR (but not Usp or any other nuclear receptor tested), a finding reminiscent of the binding of the human DOR to TR1a. Interestingly, the binding of dDOR to EcR depends upon the presence of the FENLL motif. In line with a potential role of DOR in metabolic control suggested by its down-regulation in Zucker rats, dDOR mutant flies are lean. They only have 75% of the normal triglyceride levels, and show increased levels of glycogen and trehalose, the circulating carbohydrate of insects. Such leanness is also observed after reducing EcR function, suggesting that the lean phenotype of dDOR mutants could also be due to impaired EcR signaling. Indeed, expression of the FENLL isoform, which specifically interacts with EcR, restores fat accumulation in dDOR mutants.
Following up on these results, Francis et al.
[2] uncover an interesting link between dDOR FENNL and insulin/ IGF signaling. The first hint for such a link came with the observation that dDOR FENNL expression is increased upon starvation. One important mediator of the nutritional status in the larval fat body is insulin/ IGF signaling and in particular the transcription factor dFoxO, a negative component in the pathway (Figure 1 ). Upon starvation, PI3K activity drops and dFoxO relocalizes in the nucleus of fat cells where it activates its target genes. While dDOR FENNL induction by starvation is severely compromised in dFoxO mutants, dDOR FENNL expression is strongly reduced in fat body explants treated with human insulin, both suggesting that expression of this isoform relies on dFoxO. Indeed, the promoter region of dDOR contains a consensus binding site that is bound by dFoxO in vivo. This interesting finding now places dDOR at the center of a node of regulation where insulin and ecdysone signaling converge to drive the transition from the juvenile stage to adulthood. Previous antagonistic interactions between these pathways were identified in Drosophila fat cells where ecdysone negatively controls PI3K/AKT and therefore activates dFoxO function [10] [11] [12] . Francis et al.
[2] now demonstrate the converse inhibition, where IIS restricts expression of dDOR FENNL , therefore limiting the extent of ecdysone response. They further show that dDOR FENNL is itself activated by ecdysone, and that this activation relies on dFoxO, thus creating a feed-forward activation loop on ecdysone signaling (Figure 1) .
This careful analysis of dDOR function in Drosophila constitutes an important contribution to our understanding of the molecular network between insulin/IGF and ecdysone signaling, two major antagonistic pathways controlling growth and metabolism. It also raises new questions concerning the role of the fat body in orchestrating the ecdysone response. This organ, unlike other larval tissues, specifically responds to ecdysone by blocking insulin/IGF signaling and activating dFoxO, but also by inhibiting expression of dMyc, a negative control required for the growth pause observed before maturation [12] . Therefore, dDOR FENNL [13] is alleviated and systemic growth is activated [12] . Right panel: at the end of the juvenile period, 20-hydroxy-ecdysone (20E; green) accumulates and activates the EcR/Usp receptor complex. Concomitantly, insulin/IGF signaling decreases due to limited circulating insulin-like peptides. FOXO is fully functional and activates 4EBP and dDOR FENLL expression. dMyc is inhibited by both FOXO and EcR/Usp and systemic growth pauses, while early EcR target genes are activated and trigger metamorphosis and autophagy. A feed-forward loop reinforces this transition as EcR/Usp/DOR activity represses insulin/IGF signaling, providing more FOXO activity for DOR expression. Active regulatory interactions are represented in black and inactive ones in grey.
How does cohesin regulate gene expression and development independently of its roles in sister chromatid cohesion and chromosome segregation? Recent studies show that cohesin, through multiple mechanisms, directly controls transcription of genes that regulate morphogenesis, differentiation, cell proliferation and pluripotency.
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The cohesin complex and the Nipped-B/NIPBL protein that loads it onto chromosomes ( Figure 1) were discovered nearly 15 years ago by virtue of their roles in sister chromatid cohesion, chromosome segregation, meiosis and DNA repair [1] . It was soon reported that they also regulate gene expression and development [2] , and shortly thereafter that dominant mutations affecting human NIPBL or cohesin subunits cause Cornelia de Lange syndrome (CdLS), associated with diverse structural and intellectual birth defects [3] . Gene expression and developmental effects occur without overt defects in chromosome segregation, indicating that they are independent of cohesin's role in chromatid cohesion. The mechanisms by which cohesin controls gene expression and development remain poorly understood, but recent papers report significant advances, showing that cohesin binds and regulates transcription of genes encoding key developmental regulators through multiple mechanisms (Figure 1) .
Genome-wide mapping of cohesin binding in Drosophila cells [4] , Drosophila salivary glands [5] , human lymphocytes [6] , and mouse embryonic stem cells [7] reveals that cohesin and Nipped-B/NIPBL bind preferentially to 20-50% of active genes, with peaks near the transcription start sites. Genes that bind cohesin are much more likely to be altered in expression when cohesin or Nipped-B/NIPBL activity is reduced than non-binding genes, providing prima facie evidence that cohesin directly regulates transcription [5] [6] [7] [8] .
Although genome-wide binding and expression data show that cohesin directly regulates transcription, the argument is uncertain for individual genes. In some cases expression was measured a few days after RNA interference (RNAi) knockdown of cohesin [7, 8] and thus indirect effects are possible; for example, reducing cohesin might also alter expression of transcription factors that regulate the gene. The human lymphocyte studies used cells from CdLS individuals whose development occurred in the presence of NIPBL mutations [6], and some expression changes might reflect altered development.
In this issue of Current Biology, Pauli et al.
[5] provide evidence for direct regulation of specific genes in Drosophila salivary glands. They replaced the native Rad21 cohesin subunit with a modified form that can be cleaved by tobacco etch mosaic virus (TEV) protease to release cohesin from chromosomes. Using a temperature-sensitive system to induce TEV protease, they saw changes in expression of cohesin-binding genes in the ecdysone steroid hormone pathway within four hours. With such rapid responses, chances of indirect effects are small.
For the Eip74EF gene, they confirmed that the activator, ecdysone receptor (EcR), remained bound while expression declined ten-fold.
Direct regulation of the ecdysone pathway by cohesin is important from a developmental standpoint: ecdysone is a key regulator of Drosophila morphogenesis. Reducing cohesin also blocks axon pruning by a non-dividing neuron through EcR downregulation, showing that reduced EcR expression does not reflect a defect in chromosome segregation [9, 10] . In human cells, cohesin co-localizes with the estrogen steroid hormone receptor genome-wide, and cohesin knockdown alters the cellular response to hormone, indicating that cohesin's control of steroid signaling is conserved [11] .
Recent studies also agree that genes regulated by cohesin are enriched for those that control development. In Drosophila cells derived from the central nervous system, the main ontology category for genes that increase in expression with cohesin knockdown is development [8] . The same holds true for genes whose expression increases with cohesin knockdown in mouse embryonic stem cells [7] , and many dysregulated genes in human CdLS lymphocytes [6], or Nipbl heterozygous mutant mice [12] .
Another consistent finding is that cohesin binds and regulates the myc gene, a key regulator of protein synthesis and proliferation [6-9,13]. Cohesin or Nipped-B/NIPBL reduction decreases myc expression in all species examined from flies to human. In Drosophila, many genes that are directly activated by Myc but don't bind cohesin are also downregulated, which may explain why the main ontology for genes that decrease in expression with cohesin knockdown is protein translation [8] .
